Sichuan Biokin chases Hong Kong listing after BSM drug deal
The biopharma company has yet to market any products but one of its antibody-drug conjugates is being jointly developed in a lucrative collaboration with Bristol Myers Squibb Key Takeaways: Sichuan…
FAST NEWS: AIM Vaccine’s loss balloons
The latest: Vaccine maker AIM Vaccine Co. Ltd. (6660.HK) said on Monday it expects to report a net loss of 1.25 billion yuan ($174 million) to 1.38 billion yuan for last…
FAST NEWS: AIM Vaccine named to MSCI small cap index
The latest: AIM Vaccine Co. Ltd. (6660.HK), China’s second-largest maker of non-Covid vaccines, announced Friday that its shares were selected for inclusion in the MSCI Global Small Cap Index, effective after…
FAST NEWS: CanSino Spends $21 Million on Share Buyback
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) said Friday it bought back about 670,000 of its Shanghai-listed A-shares for 147 million yuan ($20.8 million) as of Nov. 30, accounting for…
Losses Mount at InnoCare but Cash Cushion Dulls the Pain
The cancer drug developer logged another loss in the latest quarter but a cash pile of more than 9.2 billion yuan can sustain its business for the next five yearsKey…
FAST NEWS: AIM Vaccine Surges 38% on Second Trading Day
The latest: Shares of AIM Vaccine Co. Ltd. (6660.HK), China’s second-largest maker of non-Covid vaccines, surged on their second trading day Friday after a modest 3.1% gain the previous day…
FAST NEWS: BeiGene’s Lymphoma Drug Recommended to Enter European Regulator
The latest: BeiGene Ltd. (BGNE.US; 6160.HK; 668235.SH) announced Monday that its Zanubrutinib drug has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European…
